{"id":126,"date":"2026-01-03T21:28:27","date_gmt":"2026-01-03T12:28:27","guid":{"rendered":"http:\/\/osakauniversity.local\/?page_id=126"},"modified":"2026-02-20T17:56:21","modified_gmt":"2026-02-20T08:56:21","slug":"publication","status":"publish","type":"page","link":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/research\/publication\/","title":{"rendered":"Publications"},"content":{"rendered":"<p><main class=\"main-content\"><\/p>\n<div class=\"container\">\n<section class=\"publication-section\">\n<h2 class=\"year-title\">2025\u5e74<\/h2>\n<ul class=\"publication-list\">\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Long-term changes in hepatic reserve and prognosis after direct-acting antiviral treatment in patients with hepatitis C virus-related decompensated cirrhosis: a five-year follow-up study of a Japanese phase 3 trial.<\/span><span class=\"pub-authors\">Tahata Y, Hikita H, Takaki A, Kurosaki M, Matsuura K, Yatsuhashi H, Kuroda H, Ueno Y, Maekawa S, Nakamura M, Sakamori R, Kodama T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-025-02312-1\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2025 Oct 30. in press.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma<\/span><span class=\"pub-authors\">Maesaka K, Hikita H, Tahata Y, Nishioka C, Kai M, Shirai K, Murai K, Makino Y, Saito Y, Kodama T, Ohkawa K, Miyazaki M, Nozaki Y, Yakushijin T, Sakamori R, Tatsumi N, Matsumoto K, Ishida H, Iio S, Nawa T, Kakita N, Nakahara M, Hosui A, Yoshida Y, Usui T, Imanaka K, Doi Y, Sakakibara M, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-025-02308-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2025 Oct 25. in press.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Outcomes of additional chemotherapy for esophageal squamous cell carcinoma following non-curative endoscopic submucosal dissection.<\/span><span class=\"pub-authors\">Adachi Y, Hayashi Y, Yoneda S, Tajiri A, Fukuda H, Kimura E, Nakagawa K, Saiki H, Uema R, Yoshihara T, Tsujii Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10147-025-02893-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Int J Clin Oncol. 2025 Dec;30(12):2567-2575.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">First-in-Human Study of [211At]NaAt as Targeted \u03b1-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial).<\/span><span class=\"pub-authors\">Watabe T, Mukai K, Naka S, Sasaki H, Kamiya T, Hayakawa T, Fukuhara A, Takano T, Shirakami Y, Ooe K, Shigeno S, Okamura S, Masumura K, Hida E, Haba H, Toyoshima A, Isohashi K, Shimomura I, Tomiyama N.<\/span><a href=\"https:\/\/doi.org\/10.2967\/jnumed.125.270810\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Nucl Med. 2025 Sep 25:jnumed.125.270810.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination<\/span><span class=\"pub-authors\">Myojin Y, Hikita H, Tahata Y, Fukumoto K, Kato S, Sasaki Y, Kumazaki S, Tsuchiya A, Enomoto M, Miki D, Yatsuhashi H, Kuroda H, Uchida Y, Yoshiji H, Yamashita T, Mawatari S, Tamaki N, Miyaaki H, Asahina Y, Suda G, Matsuura K, Nakamoto Y, Hiasa Y, Takami T, Shirai K, Maesaka K, Murai K, Makino Y, Saito Y, Kodama T, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.70041\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2025 Sep 18. in press.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma<\/span><span class=\"pub-authors\">Maesaka K, Hikita H, Kai M, Tahata Y, Shirai K, Doi A, Murai K, Saito Y, Yamada R, Kodama T, Ohkawa K, Miyazaki M, Ishida H, Matsumoto K, Nozaki Y, Yakushijin T, Sakamori R, Tatsumi N, Iio S, Nawa T, Kakita N, Nakahara M, Hosui A, Usui T, Imanaka K, Doi Y, Sakakibara M, Yoshida Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.70068\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2025 Oct;40(10):2580-2590.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Safety and effectiveness of oral budesonide after endoscopic balloon dilation in patients with Crohn&#x27;s disease : A multicenter prospective intervention study<\/span><span class=\"pub-authors\">Otake-Kasamoto Y, Yoshihara T, Shinzaki S, Yamada T, Ogawa H, Sakakibara Y, Hiyama S, Tsujii Y, Asakura A, Tashiro T, Amano T, Tani M, Uema R, Tsujii Y, Inoue T, Iijima H, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1159\/000547608\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Inflamm Intest Dis. 2025;10:254-264.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs<\/span><span class=\"pub-authors\">Murai K, Hikita H, Yamada R, Nishimura Y, Miyazaki M, Ishida H, Hosui A, Sakamori R, Tatsumi N, Ohkawa K, Doi Y, Nawa T, Egawa S, Yoshida Y, Nozaki Y, Imanaka K, Nakahara M, Sakakibara M, Yakushijin T, Ogawa H, Usui T, Matsumoto K, Oze T, Kuriki S, Sometani E, Jihyun Sung, Shimoda A, Shigeno S, Maesaka K, Shirai K, Doi A, Tahata Y, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.14225\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2025 Sep;55(9):1228-1238.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study<\/span><span class=\"pub-authors\">Amano T, Yoshihara T, Nishida T, Sakakibara Y, Yamada T, Hiyama S, Murayama Y, Osugi N, Ogiyama H, Nagaike K, Arimoto Y, Kawai S, Yamaguchi T, Kitamura S, Ogawa H, Egawa S, Ishii S, Kizu T, Komori M, Tsujii Y, Asakura A, Tashiro T, Tani M, Otake-Kasamoto Y, Uema R, Tsujii Y, Inoue T, Shinzaki S, Iijima H, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1093\/crocol\/otaf038\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Crohns Colitis 360. 2025 May 30;7(3):otaf038.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in Fibroblasts<\/span><span class=\"pub-authors\">Kimura E, Hayashi Y, Nakagawa K, Saiki H, Kato M, Uema R, Inoue T, Yoshihara T, Sakatani A, Fukuda H, Tajiri A, Adachi Y, Murai K, Yoshii S, Tsujii Y, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/cas.70026\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancer Sci. 2025 Jul;116(7):1871-1882.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Leucine-rich Alpha-2 glycoprotein could be clinically useful in active and postoperative Crohn\u2019s disease<\/span><span class=\"pub-authors\">Tashiro T, Shinzaki S, Yoshihara T, Tsujii Y, Asakura A, Amano T, Tani M, Otake-Kasamoto Y, Uema R, Tsujii Y, Inoue T, Ogino T, Iijima H, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-025-93831-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2025 Mar 16;15(1):9031.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma<\/span><span class=\"pub-authors\">Shiode Y, Kodama T, Sato Y, Takahashi R, Matsumae T, Shirai K, Doi A, Tahata Y, Hikita H, Tatsumi T, Fukai M, Taketomi A, Ruchirawat M, Wang XW, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1186\/s40364-025-00752-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Biomark Res. 2025 Mar 4;13(1):37.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Low skeletal muscle mass contributes to the prognosis of patients with superficial esophageal cancer treated with definitive chemoradiotherapy<\/span><span class=\"pub-authors\">Nakagawa K, Hayashi Y, Adachi Y, Tajiri A, Fukuda H, Kimura E, Uema R, Saiki H, Kato M, Inoue T, Yoshihara T, Yoshii S, Tsujii Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10388-025-01109-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Esophagus. 2025 Apr;22(2):198-206.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Utility and clinical significance of endoscopic ultrasound-guided tissue acquisition for diagnosing lymphadenopathies in biliary tract cancer<\/span><span class=\"pub-authors\">Sato K, Shigekawa M, Yamamoto S, Matsumae T, Sato Y, Yoshioka T, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-025-87473-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2025 Jan 27;15(1):3363.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Feasibility and safety of endoscopic submucosal dissection for superficial cancer of the remnant esophagus after esophagectomy<\/span><span class=\"pub-authors\">Tsujii Y, Hayashi Y, Uema R, Saiki H, Kimura E, Nakagawa K, Fukuda H, Tajiri A, Adachi Y, Yoshihara T, Inoue T, Kato M, Yoshii S, Suzuki M, Makino T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10388-024-01100-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Esophagus. 2025 Apr;22(2):148-156.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">A rare case of a malignant hepatic perivascular epithelioid cell tumor (PEComa) with aggressive progression following the relapse of renal pecoma despite everolimus therapy<\/span><span class=\"pub-authors\">Kitagawa A, Nishio A, Hikita H, Kato T, Doi A, Sato K, Tahara S, Kimura Y, Ono Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s12328-024-02085-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Clin J Gastroenterol. 2025 Apr;18(2):343-351.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching<\/span><span class=\"pub-authors\">Yoshihara T, Amano T, Shinzaki S, Tsujii Y, Asakura A, Tashiro T, Tani M, Otake-Kasamoto Y, Yamada T, Sakakibara Y, Osugi N, Ishii S, Egawa S, Araki M, Arimoto Y, Nakahara M, Murayama Y, Kobayashi I, Kinoshita K, Ogawa H, Hiyama S, Shibukawa N, Komori M, Okuda Y, Kizu T, Kitamura T, Kato M, Tsujii Y, Inoue T, Iijima H, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-024-77365-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2025 Jan 2;15(1):68.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Complete Response of Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus and Right Atrium Involvement to Combined Radiotherapy and Immunotherapy: A Case Report<\/span><span class=\"pub-authors\">Daiku K, Nishio A, Hikita H, Doi A, Hayashi K, Kato S, Sasaki Y, Shimoda A, Kudo S, Fukumoto K, Maesaka K, Matsumae T, Shirai K, Sato K, Murai K, Tahata Y, Yoshioka T, Furuta K, Kodama T, Tatsumi T, Ogawa K, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.gastha.2025.100634\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gastro Hep Adv. 2025 Feb 1;4(5):100634.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Intrahepatic Exhausted Antiviral Immunity in an Immunocompetent Mouse Model of Chronic Hepatitis B<\/span><span class=\"pub-authors\">Shigeno S, Kodama T, Murai K, Motooka D, Fukushima A, Nishio A, Hikita H, Tatsumi T, Okamoto T, Kanto T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101412\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cell Mol Gastroenterol Hepatol. 2025;19(1):101412.<\/span><\/a>\n            <\/li>\n<\/ul>\n<\/section>\n<section class=\"publication-section\">\n<h2 class=\"year-title\">2024\u5e74<\/h2>\n<ul class=\"publication-list\">\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease<\/span><span class=\"pub-authors\">Amano T, Yoshihara T, Shinzaki S, Sakakibara Y, Yamada T, Osugi N, Hiyama S, Murayama Y, Nagaike K, Ogiyama H, Yamaguchi T, Arimoto Y, Kobayashi I, Kawai S, Egawa S, Kizu T, Komori M, Tsujii Y, Asakura A, Tashiro T, Tani M, Otake-Kasamoto Y, Uema R, Kato M, Tsujii Y, Inoue T, Yamada T, Kitamura T, Yonezawa A, Iijima H, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-024-80285-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2024 Nov 29;14(1):29755.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy.<\/span><span class=\"pub-authors\">Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Ido A, Miki D, Kurosaki M, Yoshiji H, Sakamori R, Kuroda H, Yatsuhashi H, Yamashita T, Hiasa Y, Kato N, Miyaaki H, Ueno Y, Itoh Y, Matsuura K, Takami T, Asahina Y, Suda G, Akuta N, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Miyazaki M, Nozaki Y, Sobue S, Yano H, Miyaki T, Moriuchi A, Hori T, Shirai K, Murai K, Saito Y, Kodama T, Tatsumi T, Yamada T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.14131\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2024 Oct 29. in press.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.<\/span><span class=\"pub-authors\">Sometani E, Hikita H, Murai K, Toyoda H, Tanaka S, Oze T, Sung J, Shimoda A, Fukuoka M, Shigeno S, Fukutomi K, Shirai K, Tahata Y, Saito Y, Nishio A, Furuta K, Kodama T, Sakamori R, Tatsumi T, Mita E, Umezawa A, Tanaka Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.14111\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2024 Sep 18. in press.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Development of a hepatic differentiation method in 2D culture from primary human hepatocyte-derived organoids for pharmaceutical research.<\/span><span class=\"pub-authors\">Ueyama-Toba Y, Tong Y, Yokota J, Murai K, Hikita H, Eguchi H, Takehara T, Mizuguchi H.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.isci.2024.110778\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">iScience. 2024 Aug 22;27(9):110778.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Collaborative orchestration of BH3-only proteins governs Bak\/Bax-dependent hepatocyte apoptosis under antiapoptotic protein-deficiency in mice<\/span><span class=\"pub-authors\">Kudo S, Hikita H, Saito Y, Murai K, Kodama T, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.21203\/rs.3.rs-4704982\/v1\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cell Death Differ. 2025 Jun;32(6):1153-1166.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy.<\/span><span class=\"pub-authors\">Furuse J, Ikeda M, Ueno M, Furukawa M, Morizane C, Takehara T, Nishina T, Todaka A, Okano N, Hara K, Nakai Y, Ohkawa K, Sasaki T, Sugimori K, Yokoyama N, Yamamoto K.<\/span><a href=\"https:\/\/doi.org\/10.1158\/1078-0432.ccr-24-0461\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Clin Cancer Res. 2024 Sep 13;30(18):3990-3995.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis.<\/span><span class=\"pub-authors\">Kumazaki S, Hikita H, Tahata Y, Sung JH, Fukumoto K, Myojin Y, Sakane S, Murai K, Sasaki Y, Shirai K, Saito Y, Kodama T, Kakita N, Takahashi H, Toyoda H, Suda G, Morii E, Kojima T, Ebihara T, Shimizu K, Sasaki Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/apt.18063\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Aliment Pharmacol Ther. 2024 Aug;60(3):327-339.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD.<\/span><span class=\"pub-authors\">Sakane S, Hikita H, Shirai K, Sakamoto T, Narumi R, Adachi J, Kakita N, Yamada Y, Toyoda H, Takahashi H, Suda G, Kai M, Tahata Y, Sakamori R, Kumazaki S, Fukumoto K, Myojin Y, Murai K, Kodama T, Tatsumi T, Tomonaga T, Sakamoto N, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1097\/hc9.0000000000000448\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Commun. 2024 Jun 3;8(6):e0448.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.<\/span><span class=\"pub-authors\">Sato K, Hikita H, Shigekawa M, Soma K, Yamauchi R, Sung J, Kato S, Sasaki Y, Kudo S, Fukumoto K, Shirai K, Murai K, Tahata Y, Yoshioka T, Nishio A, Saito Y, Kodama T, Sasaki Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-024-62498-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2024 May 26;14(1):12028.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">A machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria.<\/span><span class=\"pub-authors\">Kato M, Hayashi Y, Uema R, Kanesaka T, Yamaguchi S, Maekawa A, Yamada T, Yamamoto M, Kitamura S, Inoue T, Yamamoto S, Kizu T, Takeda R, Ogiyama H, Yamamoto K, Aoi K, Nagaike K, Sasai Y, Egawa S, Akamatsu H, Ogawa H, Komori M, Akihiro N, Yoshihara T, Tsujii Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10120-024-01511-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gastric Cancer. 2024 Sep;27(5):1069-1077.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">A novel artificial intelligence\u2013based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer.<\/span><span class=\"pub-authors\">Uema R, Hayashi Y, Kizu T, Igura T, Ogiyama H, Yamada T, Takeda R, Nagai K, Inoue T, Yamamoto M, Yamaguchi S, Kanesaka T, Yoshihara T, Kato M, Yoshii S, Tsujii Y, Shinzaki S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-024-02102-1\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2024 Jul;59(7):543-555.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.<\/span><span class=\"pub-authors\">Tajiri A, Tsujii Y, Nishida T, Inoue T, Maekawa A, Kitamura S, Yamaguchi S, Nishihara A, Yamada T, Ogiyama H, Murayama Y, Yamamoto S, Egawa S, Uema R, Yoshihara T, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/cam4.7242\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancer Med. 2024 May;13(9):e7242.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Lysophosphatidylserines derived from microbiota in Crohn&#x27;s disease elicit pathological Th1 response.<\/span><span class=\"pub-authors\">Otake-Kasamoto Y, Kayama H, Kishikawa T, Shinzaki S, Tashiro T, Amano T, Tani M, Yoshihara T, Li B, Tani H, Liu L, Hayashi A, Okuzaki D, Motooka D, Nakamura S, Okada Y, Iijima H, Takeda K, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1096\/lrmc2023.s04.p02\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Exp Med. 2022 Jul 4;219(7):e20211291.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer.<\/span><span class=\"pub-authors\">Yano T, Hayashi Y, Ishihara R, Iijima K, Iwakiri K, Uesato M, Oyama T, Katada C, Kawada K, Kushima R, Tateishi Y, Fujii S, Manabe N, Minami H, Kawakubo H, Tsubosa Y, Yamamoto S, Kadota T, Minashi K, Takeuchi H, Doki Y, Muto M.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10388-024-01043-1\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Esophagus. 2024 Apr;21(2):85-94.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary mucinous neoplasia.<\/span><span class=\"pub-authors\">Yoshioka T, Shigekawa M, Ikezawa K, Hirao M, Ishii S, Suda T, Kegasawa T, Matsumoto K, Iwahashi K, Murata J, Kaneko A, Nakazuru S, Yamamoto S, Matsumae T, Kozumi K, Sato Y, Okabe J, Sato K, Hikita H, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.pan.2023.11.005\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Pancreatology. 2024 Feb;24(1):73-77.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Genome-wide loss-of-function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus-integrated hepatoma cells.<\/span><span class=\"pub-authors\">Fukuoka M, Kodama T, Murai K, Hikita H, Sometani E, Sung J, Shimoda A, Shigeno S, Motooka D, Nishio A, Furuta K, Tatsumi T, Yusa K, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/cas.16070\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancer Sci. 2024 Mar;115(3):859-870.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study.<\/span><span class=\"pub-authors\">Kai M, Hikita H, Kazuki M, Tahata Y, Shinkai K, Doi A, Ohkawa K, Miyazaki M, Ishida H, Matsumoto K, Nozaki Y, Yakushijin T, Sakamori R, Kaneko A, Iio S, Nawa T, Kakita N, Morishita N, Hiramatsu N, Usui T, Imanaka K, Doi Y, Sakakibara M, Yoshida Y, Oze T, Kodama T, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0294590\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2024 Jan 2;19(1):e0294590.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Endoscopic features of synchronous multiple early gastric cancers: Findings from a nationwide cohort.<\/span><span class=\"pub-authors\">Hayashi Y, Hatta W, Tsuji Y, Yoshio T, Yabuuchi Y, Hoteya S, Tsuji S, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Kurakami H, Fujishiro M, Masamune A, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1159\/000538941\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Digestion. 2024;105(4):266-279.<\/span><\/a>\n            <\/li>\n<\/ul>\n<\/section>\n<section class=\"publication-section\">\n<h2 class=\"year-title\">2023\u5e74<\/h2>\n<ul class=\"publication-list\">\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan &#8211; a multicenter collaborative observational study.<\/span><span class=\"pub-authors\">Murai K, Hikita H, Kodama T, Kaibori M, Nishimura Y, Tatsumi T, Yamada T, Kanto T, Mochida S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13990\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2024 May;54(5):439-450.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Non-Pure Intestinal Phenotype as an Indicator of Progression in Sporadic Nonampullary Duodenal Adenomas: A Multicenter Retrospective Cohort Study.<\/span><span class=\"pub-authors\">Uema R, Hayashi Y, Komori M, Shibukawa N, Hayashi N, Horimoto M, Yamada T, Yamamoto M, Hiyama S, Kinoshita K, Ogiyama H, Yamaguchi S, Egawa S, Kanesaka T, Kato M, Yoshii S, Tsujii Y, Keiichiro H, Shinzaki S, Iijima H, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.14309\/ctg.0000000000000649\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Clin Transl Gastroenterol. 2024 Jan 1;15(1):e00649.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Endoscopic submucosal dissection for early gastric cancer in a patient after left ventricular assist device implantation: A case report.<\/span><span class=\"pub-authors\">Kuriki S, Tsujii Y, Saiki H, Amano T, Uema R, Kato M, Yoshihara T, Hayashi Y, Hikita H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/deo2.316\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">DEN Open. 2023 Nov 14;4(1):e316.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The apelin-apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells.<\/span><span class=\"pub-authors\">Saiki H, Hayashi Y, Yoshii S, Kimura E, Nakagawa K, Kato M, Uema R, Inoue T, Sakatani A, Yoshihara T, Tsujii Y, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.3892\/ijo.2023.5587\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Int J Oncol. 2023 Dec;63(6):139.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality.<\/span><span class=\"pub-authors\">Takahama S, Yoshio S, Masuta Y, Murakami H, Sakamori R, Kaneko S, Honda T, Murakawa M, Sugiyama M, Kurosaki M, Asahina Y, Takehara T, Appay V, Kanto T, Yamamoto T.<\/span><a href=\"https:\/\/doi.org\/10.3389\/fimmu.2023.1257113\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Front Immunol. 2023 Oct 18;14:1257113.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.<\/span><span class=\"pub-authors\">Tahata Y, Hikita H, Mochida S, Enomoto N, Ido A, Kuroda H, Miki D, Kurosaki M, Hiasa Y, Sakamori R, Kawada N, Yamashita T, Suda G, Yatsuhashi H, Yoshiji H, Kato N, Takami T, Nakao K, Matsuura K, Asahina Y, Itoh Y, Tateishi R, Nakamoto Y, Kakazu E, Terai S, Shimizu M, Ueno Y, Akuta N, Miyazaki M, Nozaki Y, Kabayama M, Sobue S, Moriuchi A, Miyaki T, Kodama T, Tatsumi T, Yamada T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-023-02039-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2023 Dec;58(12):1211-1221.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.<\/span><span class=\"pub-authors\">Okabe J, Kodama T, Sato Y, Shigeno S, Matsumae T, Daiku K, Sato K, Yoshioka T, Shigekawa M, Higashiguchi M, Kobayashi S, Hikita H, Tatsumi T, Okamoto T, Satoh T, Eguchi H, Akira S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1186\/s13046-023-02831-w\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Exp Clin Cancer Res. 2023 Oct 9;42(1):262.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">A novel role for Helicobacter pylori cytotoxin-associated gene A in negative regulation of autophagy in human gastric cells.<\/span><span class=\"pub-authors\">Sakatani A, Hayashi Y, Saiki H, Kato M, Uema R, Inoue T, Kimura K, Yoshii S, Tsujii Y, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1186\/s12876-023-02944-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">BMC Gastroenterol. 2023 Sep 22;23(1):326.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, doubleblind, active-controlled, randomised, phase 2b trial.<\/span><span class=\"pub-authors\">Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group.<\/span><a href=\"https:\/\/doi.org\/10.1016\/s2468-1253(23)00148-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Efficacy and associated factors of endoscopic transpapillary drainage for postoperative biliary leakage.<\/span><span class=\"pub-authors\">Murata J, Shigekawa M, Ishii S, Suda T, Ikezawa K, Hirao M, Matsumoto K, Kegasawa T, Iwahashi K, Iio S, Nakanishi F, Nakazuru S, Yoshida Y, Yamai T, Sato K, Yoshioka T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/deo2.281\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">DEN Open. 2023 Aug 17;4(1):e281.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Carbon dioxide insufflation reduces the relapse of ulcerative colitis after colonoscopy: A randomized controlled trial.<\/span><span class=\"pub-authors\">Otake-Kasamoto Y, Shinzaki S, Hiyama S, Tashiro T, Amano T, Tani M, Yoshihara T, Inoue T, Kawai S, Yoshii S, Tsujii Y, Hayashi Y, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0290329\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2023 Aug 17;18(8):e0290329.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Endoscopic lesions of postoperative anastomotic area in patients with Crohn&#x27;s disease in the biologic era: A Japanese multi-center nationwide cohort study.<\/span><span class=\"pub-authors\">Ueda T, Koyama F, Sugita A, Ikeuchi H, Futami K, Fukushima K, Nezu R, Iijima H, Mizushima T, Itabashi M, Watanabe K, Hata K, Shinagawa T, Matsuoka K, Takenaka K, Sasaki M, Nagayama M, Yamamoto H, Shinozaki M, Fujiya M, Kato J, Ueno Y, Tanaka S, Okita Y, Hashimoto Y, Kobayashi T, Koganei K, Uchino M, Fujii H, Suzuki Y, Hisamatsu T.<\/span><a href=\"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad116\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Crohns Colitis. 2023 Dec 30;17(12):1968-1979.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Concomitant Clostridioides difficile and Edwardsiella tarda Infection in a Patient with Ulcerative Colitis.<\/span><span class=\"pub-authors\">Fukuda H, Shinzaki S, Doi A, Yoshii S, Yoshioka T, Tsujii Y, Inoue T, Sakamori R, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.2169\/internalmedicine.0571-22\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Intern Med. 2023 Jun 15;62(12):1757-1763.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">HepaSH cells: Experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes.<\/span><span class=\"pub-authors\">Uehara S, Higuchi Y, Yoneda N, Ito R, Takahashi T, Murayama N, Yamazaki H, Murai K, Hikita H, Takehara T, Suemizu H.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.054\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Biochem Biophys Res Commun. 2023 Jun 30;663:132-141.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.<\/span><span class=\"pub-authors\">Tani M, Shinzaki S, Asakura A, Tashiro T, Amano T, Otake-Kasamoto Y, Yoshihara T, Yoshii S, Tsujii Y, Hayashi Y, Inoue T, Motooka D, Nakamura S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0283880\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2023 Apr 18;18(4):e0283880.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.<\/span><span class=\"pub-authors\">Teranishi R, Takahashi T, Nishida T, Kurokawa Y, Nakajima K, Koh M, Nishigaki T, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Motoori M, Omori T, Hirota S, Hayashi Y, Takehara T, Eguchi H, Doki Y.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10147-023-02325-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Int J Clin Oncol. 2023 May;28(5):680-687.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta-analyses.<\/span><span class=\"pub-authors\">Yoshihara T, Shinzaki S, Iijima H, Tsujii Y, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.16161\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2023 May;38(5):830-832.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Endoscopic features and clinical course of colorectal carcinoma resected by cold snare polypectomy.<\/span><span class=\"pub-authors\">Yoshii S, Hayashi Y, Nakamura T, Nishiyama O, Nagaike K, Nakamatsu D, Yamada T, Egawa S, Ogiyama H, Yamaguchi S, Inoue T, Uema R, Kato M, Inoue T, Tsujii Y, Shinzaki S, Iijima H, Michida T, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.16145\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2023 Jun;38(6):948-954.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Doi A, Tahata Y, Ohkawa K, Oshita M, Miyazaki M, Yakushijin T, Nozaki Y, Matsumoto K, Tanaka S, Kaneko A, Iio S, Nawa T, Yamada Y, Morishita N, Usui T, Hiramatsu N, Doi Y, Sakakibara M, Imanaka K, Yoshida Y, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0281459\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2023 Feb 7;18(2):e0281459.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral.<\/span><span class=\"pub-authors\">Matsumae T, Kodama T, Tahata Y, Myojin Y, Doi A, Nishio A, Yamada R, Nozaki Y, Oshita M, Hiramatsu N, Morishita N, Ohkawa K, Hijioka T, Sakakibara M, Doi Y, Kakita N, Yakushijin T, Sakamori R, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.3390\/cancers15020463\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancers (Basel). 2023 Jan 11;15(2):463.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.<\/span><span class=\"pub-authors\">Nakase H, Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Takeuchi K, Tamura S, Kinjo F, Ueno N, Naganuma M, Watanabe K, Moroi R, Nishimata N, Motoya S, Kurahara K, Takahashi S, Maemoto A, Sakuraba H, Saruta M, Tominaga K, Hisabe T, Tanaka H, Terai S, Hiraoka S, Takedomi H, Narimatsu K, Endo K, Nakamura M, Hisamatsu T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-022-01949-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2023 Mar;58(3):205-216.<\/span><\/a>\n            <\/li>\n<\/ul>\n<\/section>\n<section class=\"publication-section\">\n<h2 class=\"year-title\">2022\u5e74<\/h2>\n<ul class=\"publication-list\">\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Maesaka K, Doi A, Yamada R, Kodama T, Hikita H, Miyazaki M, Nozaki Y, Kaneko A, Oshita M, Tanaka S, Imanaka K, Hiramatsu N, Morishita N, Ohkawa K, Yakushijin T, Sakakibara M, Iio S, Doi Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13868\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2023 Apr;53(4):301-311.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis.<\/span><span class=\"pub-authors\">Shirai K, Hikita H, Sakamori R, Doi A, Tahata Y, Sakane S, Kamada Y, Murai K, Nishio A, Yamada R, Kodama T, Nozaki Y, Kakita N, Ishida H, Nakanishi F, Morishita N, Imanaka K, Sakakibara M, Tatsumi T, Miyoshi E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0279416\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2022 Dec 21;17(12):e0279416.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Diagnostic value of endoscopic ultrasonography for the depth of gastric cancer suspected of submucosal invasion: a multicenter prospective study.<\/span><span class=\"pub-authors\">Tsujii Y, Hayashi Y, Ishihara R, Yamaguchi S, Yamamoto M, Inoue T, Nagai K, Ogiyama H, Yamada T, Nakahara M, Kizu T, Kanesaka T, Matsuura N, Ohta T, Nakamatsu D, Yoshii S, Shinzaki S, Nishida T, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00464-022-09778-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Surg Endosc. 2023 Apr;37(4):3018-3028.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Yamada R, Kodama T, Hikita H, Hagiwara H, Oshita M, Imai Y, Hiramatsu N, Mita E, Kaneko A, Miyazaki M, Ohkawa K, Hijioka T, Fukui H, Ito T, Yamamoto K, Doi Y, Yoshida Y, Yamada Y, Yakushijin T, Tatsumi T, Takehara T; Osaka Liver Forum.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10620-022-07629-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Dig Dis Sci. 2023 May;68(5):2115-2122.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Ulcerative colitis-associated flat-appearing rectal cancer with submucosal extension.<\/span><span class=\"pub-authors\">Sakamoto T, Yoshii S, Tsujii Y, Shinzaki S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.gie.2022.08.027\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gastrointest Endosc. 2022 Dec;96(6):1085-1086.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases.<\/span><span class=\"pub-authors\">Tomofuji Y, Kishikawa T, Maeda Y, Ogawa K, Otake-Kasamoto Y, Kawabata S, Nii T, Okuno T, Oguro-Igashira E, Kinoshita M, Takagaki M, Oyama N, Todo K, Yamamoto K, Sonehara K, Yagita M, Hosokawa A, Motooka D, Matsumoto Y, Matsuoka H, Yoshimura M, Ohshima S, Shinzaki S, Nakamura S, Iijima H, Inohara H, Kishima H, Takehara T, Mochizuki H, Takeda K, Kumanogoh A, Okada Y.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.xgen.2022.100219\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cell Genom. 2022 Nov 30;2(12):100219.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss.<\/span><span class=\"pub-authors\">Sato K, Hikita H, Shigekawa M, Kato S, Sasaki Y, Shinkai K, Fukuoka M, Kudo S, Sato Y, Fukumoto K, Shirai K, Myojin Y, Sakane S, Murai K, Yoshioka T, Nishio A, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/cas.15569\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancer Sci. 2022 Dec;113(12):4311-4326.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Duodenal diverticulum metastasis from pulmonary squamous cell carcinoma diagnosed by EUS-FNA.<\/span><span class=\"pub-authors\">Sunaga K, Yoshioka T, Shigekawa M, Sato K, Sakamori R, Tatsumi T, Ukon K, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s12328-022-01693-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Clin J Gastroenterol. 2022 Dec;15(6):1061-1066.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Gastric carcinoma with lymphoid stroma partially differentiated into squamous cell carcinoma.<\/span><span class=\"pub-authors\">Inoue T, Hayashi Y, Tsujii Y, Yoshii S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.gie.2022.05.003\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gastrointest Endosc. 2022 Sep;96(3):564-565.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Endoscopic submucosal dissection in the right lateral position for early gastric cancer in the fornix.<\/span><span class=\"pub-authors\">Fukuda H, Tsujii Y, Kato M, Hayashi Y, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.vgie.2022.06.002\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">VideoGIE. 2022 Aug 5;7(9):327-330.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.<\/span><span class=\"pub-authors\">Korenaga M, Murata K, Izumi N, Tamaki N, Yokosuka O, Takehara T, Sakamoto N, Suda G, Nishiguchi S, Enomoto H, Ikeda F, Yanase M, Toyoda H, Genda T, Umemura T, Yatsuhashi H, Yamasaki K, Ide T, Toda N, Kanda T, Nirei K, Ueno Y, Haga H, Nishigaki Y, Nakane K, Omata M, Mochizuki H, Aoki Y, Imamura M, Kanto T, Mizokami M.<\/span><a href=\"https:\/\/doi.org\/10.35772\/ghm.2022.01026\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Glob Health Med. 2022 Aug 31;4(4):216-224.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Sofosbuvir-velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan.<\/span><span class=\"pub-authors\">Takehara T, Izumi N, Mochida S, Genda T, Fujiyama S, Notsumata K, Tamori A, Suzuki F, Suri V, Mercier RC, Matsuda T, Matsuda K, Kato N, Chayama K, Kumada H.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13810\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2022 Oct;52(10):833-840.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy.<\/span><span class=\"pub-authors\">Matsumae T, Kodama T, Myojin Y, Maesaka K, Sakamori R, Takuwa A, Oku K, Motooka D, Sawai Y, Oshita M, Nakabori T, Ohkawa K, Miyazaki M, Tanaka S, Mita E, Tawara S, Yakushijin T, Nozaki Y, Hagiwara H, Tahata Y, Yamada R, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.3390\/cancers14143367\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancers (Basel). 2022 Jul 11;14(14):3367.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Yamada R, Kodama T, Hikita H, Nozaki Y, Oshita M, Hiramatsu N, Miyazaki M, Mita E, Yamamoto K, Ohkawa K, Kaneko A, Ito T, Doi Y, Yakushijin T, Hijioka T, Fukui H, Imanaka K, Yoshida Y, Yamada Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13806\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2022 Oct;52(10):824-832.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients.<\/span><span class=\"pub-authors\">Shirai K, Hikita H, Sakane S, Narumi R, Adachi J, Doi A, Tanaka S, Tahata Y, Yamada R, Kodama T, Sakamori R, Tatsumi T, Mita E, Tomonaga T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0271020\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2022 Jul 7;17(7):e0271020.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report.<\/span><span class=\"pub-authors\">Yamada S, Kijima N, Kinoshita M, Shinzaki S, Sato K, Kido K, Hirayama R, Kagawa N, Takehara T, Morii E, Kishima H.<\/span><a href=\"https:\/\/doi.org\/10.25259\/sni_117_2022\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Surg Neurol Int. 2022 Jun 23;13:264.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma.<\/span><span class=\"pub-authors\">Murai H, Kodama T, Maesaka K, Tange S, Motooka D, Suzuki Y, Shigematsu Y, Inamura K, Mise Y, Saiura A, Ono Y, Takahashi Y, Kawasaki Y, Iino S, Kobayashi S, Idogawa M, Tokino T, Hashidate-Yoshida T, Shindou H, Miyazaki M, Imai Y, Tanaka S, Mita E, Ohkawa K, Hikita H, Sakamori R, Tatsumi T, Eguchi H, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/hep.32573\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatology. 2023 Jan 1;77(1):77-91.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis.<\/span><span class=\"pub-authors\">Makino Y, Hikita H, Fukumoto K, Sung JH, Sakano Y, Murai K, Sakane S, Kodama T, Sakamori R, Kondo J, Kobayashi S, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1158\/0008-5472.can-21-4390\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancer Res. 2022 Aug 16;82(16):2860-2873.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">&quot;Stardust&quot; gastric mucosa in the course of immune checkpoint inhibitor-associated gastritis.<\/span><span class=\"pub-authors\">Okamoto A, Yoshii S, Tsujii Y, Hayashi Y, Shinzaki S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.14309\/ajg.0000000000001835\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Am J Gastroenterol. 2022 Oct 1;117(10):1555.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy.<\/span><span class=\"pub-authors\">Murai K, Kodama T, Hikita H, Shimoda A, Fukuoka M, Fukutomi K, Shigeno S, Shiode Y, Motooka D, Higuchi Y, Miyakawa K, Suemizu H, Ryo A, Tahata Y, Makino Y, Yamada R, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/hep4.2014\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Commun. 2022 Sep;6(9):2474-2487.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Initial drainage-related prognostic factors for perihilar cholangiocarcinoma: A single-center retrospective study.<\/span><span class=\"pub-authors\">Sato K, Shigekawa M, Kozumi K, Okabe J, Sato Y, Tamura T, Yoshioka T, Sakamori R, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Takahashi H, Kobayashi S, Eguchi H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/deo2.127\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">DEN open. 2022 May 22;3(1):e127.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review.<\/span><span class=\"pub-authors\">Hyun Sung J, Sakamori R, Yamada R, Yoshioka T, Sakane S, Tahata Y, Shigekawa M, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.2169\/internalmedicine.7827-21\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Intern Med. 2022 May 1;61(9):1361-1365.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Exacerbation of non-steroidal anti-inflammatory drug-induced enteropathy in C-C chemokine receptor type 7-deficient mice.<\/span><span class=\"pub-authors\">Yamaguchi T, Iijima H, Yoshihara T, Tani M, Otake Y, Iwatani S, Amano T, Tashiro T, Kurahashi T, Inoue T, Tsujii Y, Hayashi Y, Inoue T, Motooka D, Nakamura S, Shinzaki S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15868\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2022 Aug;37(8):1561-1570.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration.<\/span><span class=\"pub-authors\">Shinkai K, Sakamori R, Yamada R, Tahata Y, Nozaki Y, Matsumoto K, Tawara S, Fukuda K, Yoshida Y, Tanaka S, Ito T, Doi Y, Iio S, Sakakibara M, Nakanishi F, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15853\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2022 Jun;37(6):1148-1155.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Doi A, Tahata Y, Miyazaki M, Ohkawa K, Mita E, Iio S, Nozaki Y, Yakushijin T, Imai Y, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13771\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2022 Jul;52(7):630-640.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.<\/span><span class=\"pub-authors\">Takigawa A, Sakamori R, Tahata Y, Yoshioka T, Yamada R, Kodama T, Hikita H, Yakushijin T, Ohkawa K, Hiramatsu N, Mita E, Hagiwara H, Ito T, Imai Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10620-022-07455-2\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Dig Dis Sci. 2022 Dec;67(12):5704-5711.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease.<\/span><span class=\"pub-authors\">Amano T, Shinzaki S, Asakura A, Tashiro T, Tani M, Otake Y, Yoshihara T, Iwatani S, Yamada T, Sakakibara Y, Osugi N, Ishii S, Egawa S, Araki M, Arimoto Y, Nakahara M, Murayama Y, Kobayashi I, Kinoshita K, Ogawa H, Hiyama S, Shibukawa N, Komori M, Okuda Y, Kizu T, Yoshii S, Tsujii Y, Hayashi Y, Inoue T, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-022-09455-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2022 Mar 29;12(1):5324.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The First Transileocolic Obliteration for Refractory Esophageal Varices: A Case Report and Review of the Literature.<\/span><span class=\"pub-authors\">Fujii Y, Sakamori R, Yamada R, Yoshioka T, Kodama T, Shigekawa M, Hikita H, Tanaka S, Ishida H, Mita E, Hongyo H, Higashihara H, Noda T, Eguchi H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.2169\/internalmedicine.7620-21\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Intern Med. 2022 Mar 15;61(6):835-839.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The degree of mucosal atrophy is associated with post-endoscopic submucosal dissection bleeding in early gastric cancer.<\/span><span class=\"pub-authors\">Hayashi Y, Hatta W, Tsuji Y, Yoshio T, Yabuuchi Y, Hoteya S, Tsuji S, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Miyake A, Fujishiro M, Masamune A, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15793\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2022 May;37(5):870-877.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy.<\/span><span class=\"pub-authors\">Myojin Y, Kodama T, Sakamori R, Maesaka K, Matsumae T, Sawai Y, Imai Y, Ohkawa K, Miyazaki M, Tanaka S, Mita E, Tawara S, Yakushijin T, Nozaki Y, Hagiwara H, Tahata Y, Yamada R, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.3390\/cancers14040883\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cancers (Basel). 2022 Feb 10;14(4):883.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-\u03baB-inducing kinase-mediated hepatocyte transdifferentiation.<\/span><span class=\"pub-authors\">Shiode Y, Kodama T, Shigeno S, Murai K, Tanaka S, Newberg JY, Kondo J, Kobayashi S, Yamada R, Hikita H, Sakamori R, Suemizu H, Tatsumi T, Eguchi H, Jenkins NA, Copeland NG, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/hep.32317\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatology. 2023 Feb 1;77(2):395-410.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals.<\/span><span class=\"pub-authors\">Uehara S, Higuchi Y, Yoneda N, Kawai K, Yamamoto M, Kamimura H, Iida Y, Oshimura M, Kazuki Y, Yamazaki H, Hikita H, Takehara T, Suemizu H.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.dmpk.2021.100410\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Drug Metab Pharmacokinet. 2022 Feb;42:100410.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery.<\/span><span class=\"pub-authors\">Sakamori R, Yamada R, Tahata Y, Kodama T, Hikita H, Tatsumi T, Yamada T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-021-01842-8\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2022 Feb;57(2):111-119.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis.<\/span><span class=\"pub-authors\">Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Kurosaki M, Ido A, Miki D, Yoshiji H, Takikawa Y, Sakamori R, Hiasa Y, Nakao K, Kato N, Ueno Y, Yatsuhashi H, Itoh Y, Tateishi R, Suda G, Takami T, Nakamoto Y, Asahina Y, Matsuura K, Yamashita T, Kanto T, Akuta N, Terai S, Shimizu M, Sobue S, Miyaki T, Moriuchi A, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-021-01845-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2022 Feb;57(2):120-132.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Clinical and Histopathological Features of the Differentiated Type of Early Gastric Cancer with an Unclear Lateral Demarcation.<\/span><span class=\"pub-authors\">Nagai K, Hayashi Y, Uema R, Inoue T, Kimura K, Sakatani A, Yoshii S, Tsujii Y, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1159\/000524842\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Digestion. 2022;103(5):347-356.<\/span><\/a>\n            <\/li>\n<\/ul>\n<\/section>\n<section class=\"publication-section\">\n<h2 class=\"year-title\">2021\u5e74<\/h2>\n<ul class=\"publication-list\">\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Tahata Y, Imai Y, Ohkawa K, Miyazaki M, Mita E, Ito T, Hagiwara H, Yakushijin T, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13741\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2022 Mar;52(3):298-307.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination.<\/span><span class=\"pub-authors\">Myojin Y, Hikita H, Tahata Y, Doi A, Kato S, Sasaki Y, Shirai K, Sakane S, Yamada R, Kodama T, Hagiwara H, Imai Y, Hiramatsu N, Tamura S, Yamamoto K, Ohkawa K, Hijioka T, Fukui H, Doi Y, Yamada Y, Yakushijin T, Mita E, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/apt.16691\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Aliment Pharmacol Ther. 2022 Feb;55(4):422-433.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Treatment progress and expansion in Japan: From interferon to direct-acting antiviral.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.35772\/ghm.2021.01083\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Glob Health Med. 2021 Oct 31;3(5):321-334.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct-acting anti-virals.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Yamada R, Kodama T, Hikita H, Hagiwara H, Imai Y, Hiramatsu N, Tamura S, Yamamoto K, Oshita M, Ohkawa K, Hijioka T, Fukui H, Ito T, Doi Y, Yamada Y, Yakushijin T, Yoshida Y, Tatsumi T, Takehara T; Osaka Liver Forum.<\/span><a href=\"https:\/\/doi.org\/10.1111\/apt.16632\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Aliment Pharmacol Ther. 2021 Nov;54(10):1340-1349.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver.<\/span><span class=\"pub-authors\">Urabe M, Hikita H, Saito Y, Kudo S, Fukumoto K, Mizutani N, Myojin Y, Doi A, Sato K, Sakane S, Makino Y, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/hep4.1815\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Commun. 2022 Feb;6(2):411-422.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020.<\/span><span class=\"pub-authors\">Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, Otsuka M, Tamaki N, Kogiso T, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13688\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2021 Nov;56(11):951-963.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma.<\/span><span class=\"pub-authors\">Amano T, Iijima H, Shinzaki S, Tashiro T, Iwatani S, Tani M, Otake Y, Yoshihara T, Sugimoto A, Egawa S, Yamaguchi S, Kinoshita K, Araki M, Hirao M, Sakakibara Y, Hiyama S, Ogawa H, Nagaike K, Murata J, Komori M, Okuda Y, Kizu T, Tsujii Y, Hayashi Y, Inoue T, Takahashi H, Mizushima T, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1186\/s12885-021-08724-5\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">BMC Cancer. 2021 Aug 31;21(1):978.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration.<\/span><span class=\"pub-authors\">Fukutomi K, Hikita H, Murai K, Nakabori T, Shimoda A, Fukuoka M, Yamai T, Higuchi Y, Miyakawa K, Suemizu H, Ryo A, Yamada R, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/hep4.1804\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Commun. 2022 Feb;6(2):281-296.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis.<\/span><span class=\"pub-authors\">Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, Motooka D, Kakita N, Yamada Y, Kondo Y, Tahata Y, Yamada R, Hikita H, Sakamori R, Kamada Y, Daly AK, Anstee QM, Tatsumi T, Morii E, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1002\/hep.31995\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatology. 2021 Nov;74(5):2452-2466.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature.<\/span><span class=\"pub-authors\">Kato S, Sakamori R, Yamada R, Murai K, Yoshioka T, Tahata Y, Shigekawa M, Kodama T, Hikita H, Hongyo H, Ono Y, Higashihara H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.2169\/internalmedicine.6565-20\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Intern Med. 2021 Aug 15;60(16):2617-2622.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Geriatric nutritional risk index as a prognostic indicator in elderly patients with early colorectal cancer undergoing endoscopic submucosal dissection.<\/span><span class=\"pub-authors\">Kato M, Hayashi Y, Fukuda H, Yamaguchi S, Inoue T, Ogiyama H, Kitamura S, Komori M, Yamamoto K, Yamamoto M, Nagai K, Nakahara M, Egawa S, Yamada T, Sasakawa A, Kizu T, Nishiyama O, Shichijo S, Yoshii S, Tsujii Y, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/den.14090\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Dig Endosc. 2022 Mar;34(3):569-578.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation.<\/span><span class=\"pub-authors\">Tamura T, Kodama T, Sato K, Murai K, Yoshioka T, Shigekawa M, Yamada R, Hikita H, Sakamori R, Akita H, Eguchi H, Johnson RL, Yokoi H, Mukoyama M, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1172\/jci143414\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Clin Invest. 2021 Jul 1;131(13):e143414.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.<\/span><span class=\"pub-authors\">Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-021-01788-x\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2021 Jul;56(7):593-619.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Evidence-based clinical practice guidelines for liver cirrhosis 2020.<\/span><span class=\"pub-authors\">Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13678\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2021 Jul;51(7):725-749.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis.<\/span><span class=\"pub-authors\">Mizutani N, Hikita H, Saito Y, Myojin Y, Sato K, Urabe M, Kurahashi T, Shiode Y, Sakane S, Murai K, Nozaki Y, Kodama T, Sakamori R, Yoshida Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1152\/ajpgi.00370.2020\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Am J Physiol Gastrointest Liver Physiol. 2021 Jun 1;320(6):G958-G968.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.<\/span><span class=\"pub-authors\">Hirano J, Yoshio S, Sakai Y, Songling L, Suzuki T, Itoh Y, Zhang H, Chen DV, Haga S, Oomori H, Kodama T, Maeda Y, Ono Y, Takahashi Y, Standley DM, Yamamoto M, Moriishi K, Moriya K, Kanto T, Takehara T, Koike K, Matsuura Y, Okamoto T.<\/span><a href=\"https:\/\/doi.org\/10.1073\/pnas.2026184118\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Proc Natl Acad Sci U S A. 2021 Jun 1;118(22):e2026184118.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.<\/span><span class=\"pub-authors\">Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T, Shiotani A, Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-021-01793-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2021 Jun;56(6):560-569.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.<\/span><span class=\"pub-authors\">Myojin Y, Hikita H, Sugiyama M, Sasaki Y, Fukumoto K, Sakane S, Makino Y, Takemura N, Yamada R, Shigekawa M, Kodama T, Sakamori R, Kobayashi S, Tatsumi T, Suemizu H, Eguchi H, Kokudo N, Mizokami M, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1053\/j.gastro.2020.12.015\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gastroenterology. 2021 Apr;160(5):1741-1754.e16.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Tahata Y, Ohkawa K, Oshita M, Tamura S, Hagiwara H, Mita E, Yakushijin T, Inada M, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.21873\/anticanres.14993\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Anticancer Res. 2021 Apr;41(4):2187-2192.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Rebleeding in patients with delayed bleeding after endoscopic submucosal dissection for early gastric cancer.<\/span><span class=\"pub-authors\">Hashimoto M, Hatta W, Tsuji Y, Yoshio T, Yabuuchi Y, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Fujishiro M, Masamune A, Ohira H; Collaborators.<\/span><a href=\"https:\/\/doi.org\/10.1111\/den.13943\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Dig Endosc. 2021 Nov;33(7):1120-1130.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Use of a convolutional neural network for classifying microvessels of superficial esophageal squamous cell carcinomas.<\/span><span class=\"pub-authors\">Uema R, Hayashi Y, Tashiro T, Saiki H, Kato M, Amano T, Tani M, Yoshihara T, Inoue T, Kimura K, Iwatani S, Sakatani A, Yoshii S, Tsujii Y, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15479\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2021 Aug;36(8):2239-2246.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Tahata Y, Oshita M, Hagiwara H, Sakakibara M, Tamura S, Hiramatsu N, Inada M, Iio S, Ito T, Yakushijin T, Doi Y, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13623\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2021 May;51(5):517-527.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis: A Case Report.<\/span><span class=\"pub-authors\">Sakamori R, Yamada R, Shinkai K, Doi A, Tahata Y, Shigekawa M, Kodaa T, Hikita H, Yamada T, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.2169\/internalmedicine.6029-20\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Intern Med. 2021;60(5):745-750.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma.<\/span><span class=\"pub-authors\">Myojin Y, Kodama T, Maesaka K, Motooka D, Sato Y, Tanaka S, Abe Y, Ohkawa K, Mita E, Hayashi Y, Hikita H, Sakamori R, Tatsumi T, Taguchi A, Eguchi H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1158\/1078-0432.ccr-20-3382\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Clin Cancer Res. 2021 Feb 15;27(4):1150-1161.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration.<\/span><span class=\"pub-authors\">Nozaki Y, Hikita H, Tanaka S, Fukumoto K, Urabe M, Sato K, Myojin Y, Doi A, Murai K, Sakane S, Saito Y, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-021-83082-7\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2021 Feb 9;11(1):3363.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn&#x27;s disease: A systematic review and meta-analysis.<\/span><span class=\"pub-authors\">Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15401\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2021 Jul;36(7):1744-1753.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis.<\/span><span class=\"pub-authors\">Kato M, Hayashi Y, Nishida T, Oshita M, Nakanishi F, Yamaguchi S, Kitamura S, Nishihara A, Akasaka T, Ogiyama H, Nakahara M, Yamada T, Kishida O, Yamamoto M, Shimayoshi A, Tsujii Y, Kato M, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15396\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2021 Aug;36(8):2083-2090.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells.<\/span><span class=\"pub-authors\">Inoue T, Hayashi Y, Tsujii Y, Yoshii S, Sakatani A, Kimura K, Uema R, Kato M, Saiki H, Shinzaki S, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.21203\/rs.3.rs-149991\/v1\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2021 Sep 30;11(1):19524.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis.<\/span><span class=\"pub-authors\">Motooka K, Morishita K, Ito N, Shinzaki S, Tashiro T, Nojima S, Shimizu K, Date M, Sakata N, Yamada M, Takamatsu S, Kamada Y, Iijima H, Mizushima T, Morii E, Takehara T, Miyoshi E.<\/span><a href=\"https:\/\/doi.org\/10.3748\/wjg.v27.i2.162\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">World J Gastroenterol. 2021 Jan 14;27(2):162-175.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.<\/span><span class=\"pub-authors\">Sakane S, Hikita H, Shirai K, Myojin Y, Sasaki Y, Kudo S, Fukumoto K, Mizutani N, Tahata Y, Makino Y, Yamada R, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.07.008\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cell Mol Gastroenterol Hepatol. 2021;12(5):1683-1699.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.<\/span><span class=\"pub-authors\">Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1159\/000514174\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Liver Cancer. 2021 Jun;10(3):181-223.<\/span><\/a>\n            <\/li>\n<\/ul>\n<\/section>\n<section class=\"publication-section\">\n<h2 class=\"year-title\">2020\u5e74<\/h2>\n<ul class=\"publication-list\">\n<li class=\"publication-item\">\n                <span class=\"pub-title\">&quot;Floating&quot; method and &quot;lifting up&quot; method: novel techniques of gastric endoscopic submucosal dissection for treating difficult-to-approach lesions.<\/span><span class=\"pub-authors\">Yoshii S, Hayashi Y, Uema R, Tsujii Y, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1055\/a-1265-6561\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Endoscopy. 2021 Sep;53(9):E324-E325.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: A Japanese real-world multicenter study.<\/span><span class=\"pub-authors\">Tahata Y, Hikita H, Mochida S, Kawada N, Enomoto N, Ido A, Yoshiji H, Miki D, Hiasa Y, Takikawa Y, Sakamori R, Kurosaki M, Yatsuhashi H, Tateishi R, Ueno Y, Itoh Y, Yamashita T, Kanto T, Suda G, Nakamoto Y, Kato N, Asahina Y, Matsuura K, Terai S, Nakao K, Shimizu M, Takami T, Akuta N, Yamada R, Kodama T, Tatsumi T, Yamada T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-020-01733-4\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2021 Jan;56(1):67-77.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Endoscopic biliary stenting as the risk factor for cholangitis after endoscopic ultrasound in patients with biliary strictures.<\/span><span class=\"pub-authors\">Ikezawa K, Shigekawa M, Yamai T, Suda T, Kegasawa T, Yoshioka T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15264\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2021 May;36(5):1263-1266.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Detection of Phosphorylated Alpha-Synuclein in the Muscularis Propria of the Gastrointestinal Tract Is a Sensitive Predictor for Parkinson&#x27;s Disease.<\/span><span class=\"pub-authors\">Beck G, Hori Y, Hayashi Y, Morii E, Takehara T, Mochizuki H.<\/span><a href=\"https:\/\/doi.org\/10.1155\/2020\/4687530\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Parkinsons Dis. 2020 Sep 23;2020:4687530.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation.<\/span><span class=\"pub-authors\">Shiode Y, Hikita H, Tanaka S, Shirai K, Doi A, Sakane S, Kai Y, Nakabori T, Yamada R, Kodama T, Narumi R, Sakamori R, Eguchi H, Tomonaga T, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-020-72294-y\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2020 Sep 17;10(1):15290.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Initial treatment response to transarterial chemoembolization as a predictive factor for Child-Pugh class deterioration prior to refractoriness in hepatocellular carcinoma.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Tahata Y, Imai Y, Oshita M, Ohkawa K, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13556\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2020 Nov;50(11):1275-1283.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension.<\/span><span class=\"pub-authors\">Maesaka K, Sakamori R, Yamada R, Urabe A, Tahata Y, Oshita M, Ohkawa K, Mita E, Hagiwara H, Tamura S, Ito T, Yakushijin T, Iio S, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13537\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2020 Sep;50(9):1091-1100.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Clinical outcomes of direct-acting antiviral treatments for hepatitis C patients after hepatocellular carcinoma are equivalent to interferon treatment.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Urabe A, Yamada R, Ohkawa K, Hiramatsu N, Hagiwara H, Oshita M, Imai Y, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13547\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2020 Oct;50(10):1118-1127.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Prophylactic clipping not effective in preventing post-polypectomy bleeding for &lt; 20-mm colon polyps: A multicenter, open-label, randomized controlled trial.<\/span><span class=\"pub-authors\">Inoue T, Ishihara R, Nishida T, Akasaka T, Hayashi Y, Nakamatsu D, Ogiyama H, Yamaguchi S, Yamamoto K, Mukai A, Kinoshita K, Yakushijin T, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15134\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2021 Feb;36(2):383-390.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Oligosaccharide-dependent anti-inflammatory role of galectin-1 for macrophages in ulcerative colitis.<\/span><span class=\"pub-authors\">Iwatani S, Shinzaki S, Amano T, Otake Y, Tani M, Yoshihara T, Tsujii Y, Hayashi Y, Inoue T, Okuzaki D, Mizushima T, Miyoshi E, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15097\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2020 Dec;35(12):2158-2169.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.<\/span><span class=\"pub-authors\">Sato K, Hikita H, Myojin Y, Fukumoto K, Murai K, Sakane S, Tamura T, Yamai T, Nozaki Y, Yoshioka T, Kodama T, Shigekawa M, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0235573\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2020 Jul 1;15(7):e0235573.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Lower serum sodium levels are associated with the therapeutic effect of sorafenib on hepatocellular carcinoma.<\/span><span class=\"pub-authors\">Kegasawa T, Sakammori R, Maesaka K, Yamada R, Tahata Y, Urabe A, Kodama T, Hikita H, Imanaka K, Ohkawa K, Hiramatsu N, Oshita M, Yamada Y, Inada M, Yakushijin T, Imai Y, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s10620-020-06380-6\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Dig Dis Sci. 2021 May;66(5):1720-1729.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Pre-existing Minor Variants With NS5A L31M\/V-Y93H Double Substitution Are Closely Linked to Virologic Failure With Asunaprevir Plus Daclatasvir Treatment for Genotype 1b Hepatitis C Virus Infection.<\/span><span class=\"pub-authors\">Morishita N, Sakamori R, Yamada T, Kai Y, Tahata Y, Urabe A, Yamada R, Kodama T, Hikita H, Doi Y, Tamura S, Hagiwara H, Imai Y, Iio S, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0234811\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2020 Jun 16;15(6):e0234811.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study.<\/span><span class=\"pub-authors\">Kamada Y, Morishita K, Koseki M, Nishida M, Asuka T, Naito Y, Yamada M, Takamatsu S, Sakata Y, Takehara T, Miyoshi E.<\/span><a href=\"https:\/\/doi.org\/10.3390\/nu12061770\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Nutrients. 2020 Jun 12;12(6):1770.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score.<\/span><span class=\"pub-authors\">Hatta W, Tsuji Y, Yoshio T, Kakushima N, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Koike T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribayashi S, Kiyotoki S, Mabe K, Nakamura T, Nakaya N, Fujishiro M, Masamune A.<\/span><a href=\"https:\/\/doi.org\/10.1136\/gutjnl-2019-319926\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gut. 2020 Jun 4:gutjnl-2019-319926.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">SIRT1 enhances hepatitis virus B transcription independent of hepatic autophagy.<\/span><span class=\"pub-authors\">Yamai T, Hikita H, Fukuoka M, Fukutomi K, Murai K, Nakabori T, Yamada R, Miyakawa K, Watashi K, Ryo A, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bbrc.2020.04.031\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Biochem Biophys Res Commun. 2020 Jun 18;527(1):64-70.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Loss of core fucosylation reduces low-density lipoprotein receptor expression in hepatocytes by inducing PCSK9 production.<\/span><span class=\"pub-authors\">Kamada Y, Yamamoto A, Fujiyoshi A, Koseki M, Morishita K, Asuka T, Takamatsu S, Sakata Y, Takehara T, Taniguchi N, Miyoshi E.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.019\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Biochem Biophys Res Commun. 2020 Jun 30;527(3):682-688.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study.<\/span><span class=\"pub-authors\">Araki M, Shinzaki S, Yamada T, Arimitsu S, Komori M, Shibukawa N, Mukai A, Nakajima S, Kinoshita K, Kitamura S, Murayama Y, Ogawa H, Yasunaga Y, Oshita M, Fukui H, Masuda E, Tsujii M, Kawai S, Hiyama S, Inoue T, Tanimukai H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0233365\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">PLoS One. 2020 May 26;15(5):e0233365.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.<\/span><span class=\"pub-authors\">Qi X, Wang J, Li X, Wang Z, Liu Y, Yang H, Li X, Shi J, Xiang H, Liu T, Kawada N, Maruyama H, Jiang Z, Wang F, Takehara T, Rockey DC, Sarin SK; COVID-Cirrhosis-CHESS Group.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s12072-020-10051-z\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Int. 2020 Jul;14(4):478-482.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Clinical course and risk factors for mortality of COVID-19 patients with preexisting cirrhosis: a multicentre cohort study.<\/span><span class=\"pub-authors\">Qi X, Liu Y, Wang J, Fallowfield JA, Wang J, Li X, Shi J, Pan H, Zou S, Zhang H, Chen Z, Li F, Luo Y, Mei M, Liu H, Wang Z, Li J, Yang H, Xiang H, Li X, Liu T, Zheng MH, Liu C, Huang Y, Xu D, Li X, Kang N, He Q, Gu Y, Zhang G, Shao C, Liu D, Zhang L, Li X, Kawada N, Jiang Z, Wang F, Xiong B, Takehara T, Rockey DC; COVID-Cirrhosis-CHESS Group.<\/span><a href=\"https:\/\/doi.org\/10.1136\/gutjnl-2020-321666\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Gut. 2021 Feb;70(2):433-436.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease.<\/span><span class=\"pub-authors\">Iwatani S, Iijima H, Otake Y, Amano T, Tani M, Yoshihara T, Tashiro T, Tsujii Y, Inoue T, Hayashi Y, Takeda K, Hayashi A, Fujita S, Shinzaki S, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/jgh.15067\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol Hepatol. 2020 Aug;35(8):1355-1364.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Risk Factors for Pancreatic Cancer and the Necessity of Long-term Surveillance in Patients With Pancreatic Cystic Lesions.<\/span><span class=\"pub-authors\">Yoshioka T, Shigekawa M, Ikezawa K, Tamura T, Sato K, Urabe M, Sueyoshi H, Yamai T, Suda T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1097\/mpa.0000000000001521\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Pancreas. 2020 Apr;49(4):552-560.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Efficacy of vonoprazan for the prevention of bleeding after gastric endoscopic submucosal dissection with continuous use of antiplatelet agents.<\/span><span class=\"pub-authors\">Yoshii S, Yamada T, Yamaguchi S, Hayashi Y, Nakahara M, Shibukawa N, Yamamoto M, Ishihara R, Kinoshita K, Egawa S, Tsujii Y, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1055\/a-1067-4380\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Endosc Int Open. 2020 Apr;8(4):E481-E487.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Usefulness of a dedicated mouthpiece for the Valsalva maneuver to visualize the hypopharynx during transoral endoscopy.<\/span><span class=\"pub-authors\">Kato M, Hayashi Y, Uema R, Saiki H, Kimura K, Inoue T, Sakatani A, Yoshii S, Tsujii Y, Shinzaki S, Hida E, Iijima H, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1055\/a-1099-9130\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Endosc Int Open. 2020 Apr;8(4):E536-E543.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">JNJ-4178 (Adafosbuvir, Odalasvir, and Simeprevir) in Japanese Patients With Chronic Hepatitis C Virus Genotype 1 or 2 Infection With or Without Compensated Cirrhosis: The Phase IIa OMEGA-3 Study.<\/span><span class=\"pub-authors\">Takehara T, Chayama K, Kurosaki M, Yatsuhashi H, Tanaka Y, Hiramatsu N, Sakamoto N, Asahina Y, Nozaki A, Nakano T, Hagiwara Y, Shimizu H, Yoshida H, Huang Y, Michael B, Leen V, Hayashi N.<\/span><a href=\"https:\/\/doi.org\/10.1007\/s00535-020-01672-0\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">J Gastroenterol. 2020 Jun;55(6):640-652.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway.<\/span><span class=\"pub-authors\">Murai K, Hikita H, Kai Y, Kondo Y, Fukuoka M, Fukutomi K, Doi A, Yamai T, Nakabori T, Fukuda R, Takahashi T, Miyakawa K, Suemizu H, Ryo A, Yamada R, Kodama T, Sakamori R, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1038\/s41598-020-57603-9\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Sci Rep. 2020 Jan 22;10(1):941.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment.<\/span><span class=\"pub-authors\">Tahata Y, Sakamori R, Urabe A, Yamada R, Ohkawa K, Hiramatsu N, Hagiwara H, Oshita M, Hijioka T, Tamura S, Imai Y, Kodama T, Hikita H, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1111\/hepr.13454\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Hepatol Res. 2020 Mar;50(3):313-320.<\/span><\/a>\n            <\/li>\n<li class=\"publication-item\">\n                <span class=\"pub-title\">Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice.<\/span><span class=\"pub-authors\">Kurahashi T, Yoshida Y, Ogura S, Egawa M, Furuta K, Hikita H, Kodama T, Sakamori R, Kiso S, Kamada Y, Wang IC, Eguchi H, Morii E, Doki Y, Mori M, Kalinichenko VV, Tatsumi T, Takehara T.<\/span><a href=\"https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.008\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"pub-source\">Cell Mol Gastroenterol Hepatol. 2020;9(3):425-446.<\/span><\/a>\n            <\/li>\n<\/ul>\n<\/section><\/div>\n<p><\/main><\/p>\n","protected":false},"excerpt":{"rendered":"<p>2025\u5e74 Long-term changes in hepatic reserve and prognosi [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":12,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"folder":[14],"class_list":["post-126","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/pages\/126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/comments?post=126"}],"version-history":[{"count":2,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/pages\/126\/revisions"}],"predecessor-version":[{"id":461,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/pages\/126\/revisions\/461"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/pages\/12"}],"wp:attachment":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/media?parent=126"}],"wp:term":[{"taxonomy":"folder","embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/gh\/en\/wp-json\/wp\/v2\/folder?post=126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}